Baumgart DC, Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369:1627–1640

CAS  Article  Google Scholar 

Taylor H, Serrano-Contreras JI, McDonald JAK et al (2020) Multiomic features associated with mucosal healing and inflammation in paediatric Crohn’s disease. Aliment Pharmacol Ther 52:1491–1502

CAS  PubMed  Google Scholar 

Colombel JF, Sandborn WJ, Reinisch W et al (2010) Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med 362:1383–1395

CAS  Article  Google Scholar 

Kang B, Choi SY, Choi YO et al (2019) Infliximab trough levels are associated with mucosal healing during maintenance treatment with infliximab in paediatric Crohn’s disease. J Crohns Colitis 13:189–197

Article  Google Scholar 

Ventin-Holmberg R, Eberl A, Saqib S et al (2021) Bacterial and fungal profiles as markers of infliximab drug response in inflammatory bowel disease. J Crohns Colitis 15:1019–1031

Article  Google Scholar 

Kang B, Choi SY, Kim HS, Kim K, Lee YM, Choe YH (2016) Mucosal healing in paediatric patients with moderate-to-severe luminal Crohn’s disease under combined immunosuppression: escalation versus early treatment. J Crohns Colitis 10:1279–1286

Article  Google Scholar 

Dreesen E, Baert F, Laharie D et al (2020) Monitoring a combination of calprotectin and infliximab identifies patients with mucosal healing of Crohn’s disease. Clin Gastroenterol Hepatol 18:637-646.e611

Neurath MF, Travis SP (2012) Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 61:1619–1635

CAS  Article  Google Scholar 

Weinstein-Nakar I, Focht G, Church P et al (2018) Associations among mucosal and transmural healing and fecal level of calprotectin in children with Crohn’s disease. Clin Gastroenterol Hepatol 16:1089-1097.e1084

Peyrin-Biroulet L, Reinisch W, Colombel JF et al (2014) Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn’s disease in the SONIC trial. Gut 63:88–95

Article  Google Scholar 

Noh SM, Oh EH, Park SH et al (2020) Association of faecal calprotectin level and combined endoscopic and radiological healing in patients with Crohn’s disease receiving anti-tumour necrosis factor therapy. J Crohns Colitis 14:1231–1240

Article  Google Scholar 

Lin X, Qiu Y, Feng R et al (2020) Normalization of C-reactive protein predicts better outcome in patients with Crohn’s disease with mucosal healing and deep remission. Clin Transl Gastroenterol 11:e00135

Article  Google Scholar 

Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577

Article  Google Scholar 

Li X, Liang D, Meng J et al (2021) Development and validation of a novel computed-tomography enterography radiomic approach for characterization of intestinal fibrosis in Crohn’s disease. Gastroenterology 160:2303-2316.e2311

Zhu C, Yu Y, Wang S et al (2021) A novel clinical radiomics nomogram to identify Crohn’s disease from intestinal tuberculosis. J Inflamm Res 14:6511–6521

Article  Google Scholar 

Gomollón F, Dignass A, Annese V et al (2017) 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: Part 1: Diagnosis and medical management. J Crohns Colitis 11:3–25

Article  Google Scholar 

Daperno M, D’Haens G, Van Assche G et al (2004) Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 60:505–512

Article  Google Scholar 

Bruining DH, Zimmermann EM, Loftus EV Jr, Sandborn WJ, Sauer CG, Strong SA (2018) Consensus recommendations for evaluation, interpretation, and utilization of computed tomography and magnetic resonance enterography in patients with small bowel Crohn’s disease. Gastroenterology 154:1172–1194

Article  Google Scholar 

Kennedy NA, Heap GA, Green HD et al (2019) Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn’s disease: a prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol 4:341–353

Article  Google Scholar 

Magro F (2019) Anti-TNF treatment failure: drug levels, immunogenicity, or both? Lancet Gastroenterol Hepatol 4:326–327

Article  Google Scholar 

Yueying C, Jing F, Tian Y, Yuqi Q, Jun S (2021) Bioelectrical impedance analysis-based nomogram construction for predicting secondary loss of response to infliximab in bio-naïve Crohn’s disease patients. Biomed Pharmacother 142:112076

Article  Google Scholar 

Jessen B, Rodriguez-Sillke Y, Sonnenberg E et al (2021) Level of tumor necrosis factor production by stimulated blood mononuclear cells can be used to predict response of patients with inflammatory bowel diseases to infliximab. Clin Gastroenterol Hepatol 19:721-731.e721

Atreya R, Siegmund B (2021) Location is important: differentiation between ileal and colonic Crohn’s disease. Nat Rev Gastroenterol Hepatol 18:544–558

Article  Google Scholar 

Ding NS, Hart A, De Cruz P (2016) Systematic review: predicting and optimising response to anti-TNF therapy in Crohn’s disease - algorithm for practical management. Aliment Pharmacol Ther 43:30–51

CAS  Article  Google Scholar 

Bertani L, Fornai M, Fornili M et al (2020) Serum oncostatin M at baseline predicts mucosal healing in Crohn’s disease patients treated with infliximab. Aliment Pharmacol Ther 52:284–291

CAS  Article  Google Scholar 

Rimola J, Fernàndez-Clotet A, Capozzi N et al (2020) Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn’s disease. Aliment Pharmacol Ther 52:1563–1573

CAS  PubMed  Google Scholar 

Narula N, Wong ECL, Dulai PS, Marshall JK, Colombel JF, Reinisch W (2021) Week 6 calprotectin best predicts likelihood of long-term endoscopic healing in Crohn’s disease: a post-hoc analysis of the UNITI/IM-UNITI trials. J Crohns Colitis 15:462–470

Article  Google Scholar 

Hattori S, Nakamura M, Yamamura T et al (2020) The microbiome can predict mucosal healing in small intestine in patients with Crohn’s disease. J Gastroenterol 55:1138–1149

CAS  Article  Google Scholar 

Beppu T, Ono Y, Matsui T et al (2015) Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn’s disease. Dig Endosc 27:73–81

Article  Google Scholar 

Guidi L, Marzo M, Andrisani G et al (2014) Faecal calprotectin assay after induction with anti-tumour necrosis factor α agents in inflammatory bowel disease: prediction of clinical response and mucosal healing at one year. Dig Liver Dis 46:974–979

CAS  Article  Google Scholar 

Schreiber S, Colombel JF, Bloomfield R et al (2010) Increased response and remission rates in short-duration Crohn’s disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data. Am J Gastroenterol 105:1574–1582

CAS  Article  Google Scholar 

Ben-Horin S, Lahat A, Amitai MM et al (2019) Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn’s disease flare: a prospective cohort study. Lancet Gastroenterol Hepatol 4:519–528

Article  Google Scholar